Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 117 (1) , 159-164
Abstract
No abstract availableKeywords
Funding Information
- NCI (R21CA101355, R21CA135620)
- Medical Research and Materiel Command, U.S. Army Medical Department (170220051)
- Bankhead-Coley Foundation (NCT01754623)
This publication has 29 references indexed in Scilit:
- Current Controversies in the Stage-Specific Multidisciplinary Management of Pancreatic CancerAmerican Society of Clinical Oncology Educational Book, 2014
- Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cellsRadiotherapy and Oncology, 2014
- Discovery of the cancer stem cell related determinants of radioresistanceRadiotherapy and Oncology, 2013
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Long-term Survival and Metastatic Pattern of Pancreatic and Periampullary Cancer After Adjuvant Chemoradiation or ObservationAnnals of Surgery, 2007
- A challenge to the therapeutic nihilism of ESPAC-1International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Adjuvant Therapy for Pancreatic Cancer — The Debate ContinuesNew England Journal of Medicine, 2004
- The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.1998